CD33 and acute myeloid leukemia: After three weeks of xenotransplantation, the engraftment efficiency of THP-1 and MV4-11 AML cells was confirmed by monitoring CD33 + or CD45 + cells in the peripheral blood of shME2-THP-1 or shME2-MV4-11 mice (Figure S4).